๐Ÿ”ฌDeep Research

LMAT โ€” LeMaitre Vascular, Inc. ยท catalysts, narrative & risks

ยท18 sourcesLMAT forecast โ†’

LeMaitre Vascular, Inc. (NASDAQ: LMAT) โ€” Company Profile

LeMaitre Vascular develops, manufactures, and markets medical devices and implants for vascular surgery (peripheral vascular disease), including vascular grafts, catheters, patches, valvulotomes, and carotid shunts, serving the Americas, Europe, the Middle East, Africa, and Asia Pacific [16]. Founded in 1986 and headquartered in Burlington, Massachusetts, it is led by chairman/CEO George W. LeMaitre [20]. A minor correction to our own calendar: the listing exchange is Nasdaq (NASDAQ:LMAT), not "NGM" [1], [9], [14], [20].

Recent Catalysts (last ~1โ€“3 months)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’